inVibe Labs, a pioneer in the field of voice technology for market research and recently included on the Inc. 5000 list of fastest-growing companies for the third year in a row, announced key promotions to resource the company’s significant growth.
Independent agency Connelly Partners (CP) announced Sept. 13 the launch of Connelly Partners Health (CP Health), a new dedicated health practice as part of the agency’s integrated offering.
Talkatoo, creators of the easy-to-use, efficient and platform-agnostic dictation software for animal health professionals, announced the closing of a new, oversubscribed round of funding led by Klick Ventures.
Vertex Pharmaceuticals and Arbor Biotechnologies announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor’s proprietary CRISPR gene-editing technology for select diseases.
The World Health Organization defines health technology as “the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures, and systems developed to solve a health problem and improve quality of lives.” While that’s true, it’s a pretty broad statement. In an era when we’re seeing rapid technological shifts in the way people measure, monitor, and think about their health, it’s worth focusing any discussion of health technology to a few key areas that best highlight some of the more exciting – and challenging – aspects of health technology development at this point in 2021.
With a focus on how technology and vision can bring transformational innovation, WPP company CMI Media Group and NMSDC certified diverse supplier Compas announced the appointment of Oleg Korenfeld as Chief Technology Officer.
CrowdPharm, an independent full-service agency with one of healthcare’s largest networks of global talent, announced a strategic partnership with True Media to provide integrated, data-driven media strategy that influences customer behavior.
Independent, full-service health and wellness advertising agency AbelsonTaylor promoted Christopher Mauck to senior director of interactive technology.
A World Health Organization (WHO) committee said on July 12 that human genome editing technologies to treat serious disease should be shared more generously, to allow poorer nations to benefit from the highly dynamic scientific field.
ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally NEW YORK, July 1, 2021 /PRNewswire/ — ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million in its latest round of financing. The round was led by two new partners: Dedalus Group, an international healthcare IT and […]